Topic: Mental Health Research Network
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Current primary anxiety disorder identified as primary problem 2. Any psychoactive medication at a stable dose for at least two months before the initial assessment, with agreement to maintain that dose until after the laboratory assessment 3. Able to understand and speak English at an age-appropriate level 4. Parent who is primary caregiver and the person that the adolescent lives with (for the majority of the time) agrees to participate in the study 5. Target Gender: Male & Female; Upper Age Limit 18 years; Lower Age Limit 13 years
Exclusion criteria
Exclusion criteria: 1. Presence of psychotic symptoms, substance dependence, a risk of deliberate self-harm, attention deficit hyperactivity disorder (ADHD), conduct disorder, an autistic spectrum disorder or learning problems that would interfere with their understanding and participation in the trial (based on school/clinic/parent information) 2. Currently receiving therapy for their anxiety disorder 3. Parent has a significant intellectual impairment (as evidenced by them receiving a service from the local learning disabilities service) Non-anxious adolescents: Parent has a significant intellectual impairment (as evidenced by them receiving a service from the local learning disabilities service)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical diagnoses; Timepoint(s): post-treatment and at 6-month and one-year follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Added 12/04/2016: 1. Anxiety severity, measured by the ADIS-C/P 2. Self-report measure of anxiety symptoms (SCAS-C/P) 3. Impact of anxiety on the adolescent's life (CAIS-C/P) Timepoint(s): post-treatment and at 6-month and one-year follow-up | — |
Countries
United Kingdom